Hasselquistsalen, Campus University Hospital
October 19th, 2018
For the first time the biomedical programmes at Linköping University, BSc Experimental and Industrial Biomedicine and MSc Experimental and Medical Biosciences, organize the Linköping University Life Science Meeting. A one day meeting with a focus to bring together students, graduates and team members with our partners from the life science industry, academia, the health care system and invited international lecturers. The meeting will provide an arena for networking and to make our students aware of the knowledge and skills they already have or will acquire which will be required to work at the forefront of biomedical research and innovation.
08:45-09:30 Keynote speaker, Magnus Lundgren, Uppsala University The past, present and future of CRISPR-Cas
09:45-10:15 Damla Etal (alumni BSc Medbi, AstraZeneca) Cell Engineering by CRISPR and the Power of Next-Generation Sequencing in Drug Discovery
10:15-10:35 Björn Gylemo (MSc student) A CRISPR-based toolbox for alteration of gene expression
10:40-10:45 Barbara Entler and Harald Hundsberger, IMC University of Applied Sciences, Krems, Austria Erasmus exchange partner
10:45-11:00 Harald Hundsberger, IMC University of Applied Sciences, Krems, Austria The Role of NRF2 for melanoma progression
11:00-11:20 Christoph Wiesner, IMC University of Applied Sciences, Krems, Austria Innovative test systems for pre-clinical drug discovery
11:20-11:40 Lekha Pezhumkattil, double degree MSc student, University of Applied Science Technikum Wien, Austria Double degree- opportunities and obstacles
13:00-13:40 Katarina Norrby, GSK (Glaxo Smith Kline) Clinical trials in big pharma
13:40-14:10 Anders Millerhovf CTC (Clinical Trial Consultants AB) The role of a CROs (Contract Research Organisation) in clinical trials
14:10-14:30 Break 14:30-15:00 Hanna Rickberg, Apotekarsocieteten/Läkemedelsakademin Develop yourself - networking opportunities and continuous professional development (CPD)
15:00-15:15 Sara Lavasani, Moberg Pharma Clinical trials
15:15-15:45 Kristofer Katkits, Byer Health Care My journey from MedBi to Clinical Research Associate
16:00-17:00 Panel discussion
17:00 Pizza buffet
8:45-9:30: Keynote Speaker
Magnus is the principal investigator in charge of the Lundgren Lab at Uppsala University. His group investigates the CRISPR-Cas system which comprises the prokaryote cell’s adaptive and heritable immunity against viral infections. The goal is to better understand the CRISPR-Cas system and find areas for application. Magnus has previously given a lecture at HURS, for which he received a great deal of praise. Keynote lecture: ”The past, present and future of CRISPR-Cas”
9:45-10:15 Cell Engineering by CRISPR and the Power of Next-Generation Sequencing in Drug Discovery
10:15-10:35 A CRISPR-based toolbox for alteration of gene expression
10:45-11:00The Role of NRF2 for melanoma progression
11:00-11:20 Innovative test systems for pre-clinical drug discovery
11:20-11:40 Double degree- opportunities and obstacles
13:00-13:30 Clinical trials in big pharma
13:30-14.00 The role of a CROs (Contract Research Organisation) in clinical trials
14:15-14:45 Develop yourself - networking opportunities and continuous professional development (CPD)
15:00-15:30 My journey from MedBi to Clinical Research Associate
Linköping University Life Science Meeting 2018 will take place at University Hospital Campus, Hasselquistsalen
Do you have what it takes and are interested in a career within Biomedicine?
Are you interested in applying theory in Biomedicine in projects from industry, healthcare or academia? Learning how to manage running projects with skills in entrepreneurship and business development. Then the BSc program in Experimental and Industrial Biomedicine will give you exciting years!
Read more about the programme
The Experimental and Medical Biosciences master’s programme prepares students for a scientific career within the broad field of the life sciences, with particular emphasis on understanding cellular and molecular mechanisms related to health and disease.
Read more about the programme
Linköping University, LiU, conducts world-leading, boundary-crossing research in fields that include materials science, IT and hearing. In the same spirit, the university offers many innovative educational programmes, frequently with a clear professional focus and leading to qualification as, for example, doctors, teachers, economists and engineers. LiU was granted university status in 1975 and today has 27,000 students and 4,000 employees. The students are among the most desirable in the labour market and international rankings consistently place LiU as a leading global university.